Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia

Eric M. Mortensen, Marcos Restrepo, Antonio Anzueto, Jacqueline Pugh

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

National practice guidelines have recommended specific initial empiric antimicrobial regimens for patients with community-acquired pneumonia. Our aim was to determine the association between the use of guideline-concordant antimicrobial therapy and 30-day mortality in patients with pneumonia. We conducted a retrospective cohort study at two tertiary teaching hospitals. Eligible patients were admitted with a diagnosis of community-acquired pneumonia, had a chest radiograph consistent with pneumonia, and had a discharge diagnosis of pneumonia. All eligible patients were identified and a random sample was abstracted. We determined whether the use of guideline-concordant antibiotics was associated with 30-day mortality in an analysis that adjusted for potential confounders using propensity scores. Information was obtained on 420 patients with pneumonia. The mean (± SD) age was 63 ± 16 years, 355 were men, and 82 patients were initially admitted to the intensive care unit. At 30 days after presentation, 41 patients (9.8%) had died: 21 of 97 (21.7%) in the non-guideline-concordant group and 20 of 323 (6.2%) in the guideline-concordant group. Antibiotics were concordant with national guidelines in 323 patients. In the regression analysis, after adjustment for the propensity score, failure to comply with antimicrobial therapy guidelines was associated with increased 30-day mortality (odds ratio = 5.7; 95% confidence interval: 2.0 to 16.0). Receipt of antimicrobial regimens concordant with national published guidelines may reduce 30-day mortality among patients hospitalized with pneumonia. Am J Med. 2004;117:726 -731.

Original languageEnglish (US)
Pages (from-to)726-731
Number of pages6
JournalAmerican Journal of Medicine
Volume117
Issue number10
DOIs
StatePublished - Nov 15 2004

Fingerprint

Pneumonia
Guidelines
Mortality
Propensity Score
Therapeutics
Anti-Bacterial Agents
Practice Guidelines
Tertiary Care Centers
Teaching Hospitals
Intensive Care Units
Cohort Studies
Thorax
Retrospective Studies
Odds Ratio
Regression Analysis
Confidence Intervals

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. / Mortensen, Eric M.; Restrepo, Marcos; Anzueto, Antonio; Pugh, Jacqueline.

In: American Journal of Medicine, Vol. 117, No. 10, 15.11.2004, p. 726-731.

Research output: Contribution to journalArticle

@article{adfdb038896e479fb056d97f7dce7c9d,
title = "Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia",
abstract = "National practice guidelines have recommended specific initial empiric antimicrobial regimens for patients with community-acquired pneumonia. Our aim was to determine the association between the use of guideline-concordant antimicrobial therapy and 30-day mortality in patients with pneumonia. We conducted a retrospective cohort study at two tertiary teaching hospitals. Eligible patients were admitted with a diagnosis of community-acquired pneumonia, had a chest radiograph consistent with pneumonia, and had a discharge diagnosis of pneumonia. All eligible patients were identified and a random sample was abstracted. We determined whether the use of guideline-concordant antibiotics was associated with 30-day mortality in an analysis that adjusted for potential confounders using propensity scores. Information was obtained on 420 patients with pneumonia. The mean (± SD) age was 63 ± 16 years, 355 were men, and 82 patients were initially admitted to the intensive care unit. At 30 days after presentation, 41 patients (9.8{\%}) had died: 21 of 97 (21.7{\%}) in the non-guideline-concordant group and 20 of 323 (6.2{\%}) in the guideline-concordant group. Antibiotics were concordant with national guidelines in 323 patients. In the regression analysis, after adjustment for the propensity score, failure to comply with antimicrobial therapy guidelines was associated with increased 30-day mortality (odds ratio = 5.7; 95{\%} confidence interval: 2.0 to 16.0). Receipt of antimicrobial regimens concordant with national published guidelines may reduce 30-day mortality among patients hospitalized with pneumonia. Am J Med. 2004;117:726 -731.",
author = "Mortensen, {Eric M.} and Marcos Restrepo and Antonio Anzueto and Jacqueline Pugh",
year = "2004",
month = "11",
day = "15",
doi = "10.1016/j.amjmed.2004.06.028",
language = "English (US)",
volume = "117",
pages = "726--731",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia

AU - Mortensen, Eric M.

AU - Restrepo, Marcos

AU - Anzueto, Antonio

AU - Pugh, Jacqueline

PY - 2004/11/15

Y1 - 2004/11/15

N2 - National practice guidelines have recommended specific initial empiric antimicrobial regimens for patients with community-acquired pneumonia. Our aim was to determine the association between the use of guideline-concordant antimicrobial therapy and 30-day mortality in patients with pneumonia. We conducted a retrospective cohort study at two tertiary teaching hospitals. Eligible patients were admitted with a diagnosis of community-acquired pneumonia, had a chest radiograph consistent with pneumonia, and had a discharge diagnosis of pneumonia. All eligible patients were identified and a random sample was abstracted. We determined whether the use of guideline-concordant antibiotics was associated with 30-day mortality in an analysis that adjusted for potential confounders using propensity scores. Information was obtained on 420 patients with pneumonia. The mean (± SD) age was 63 ± 16 years, 355 were men, and 82 patients were initially admitted to the intensive care unit. At 30 days after presentation, 41 patients (9.8%) had died: 21 of 97 (21.7%) in the non-guideline-concordant group and 20 of 323 (6.2%) in the guideline-concordant group. Antibiotics were concordant with national guidelines in 323 patients. In the regression analysis, after adjustment for the propensity score, failure to comply with antimicrobial therapy guidelines was associated with increased 30-day mortality (odds ratio = 5.7; 95% confidence interval: 2.0 to 16.0). Receipt of antimicrobial regimens concordant with national published guidelines may reduce 30-day mortality among patients hospitalized with pneumonia. Am J Med. 2004;117:726 -731.

AB - National practice guidelines have recommended specific initial empiric antimicrobial regimens for patients with community-acquired pneumonia. Our aim was to determine the association between the use of guideline-concordant antimicrobial therapy and 30-day mortality in patients with pneumonia. We conducted a retrospective cohort study at two tertiary teaching hospitals. Eligible patients were admitted with a diagnosis of community-acquired pneumonia, had a chest radiograph consistent with pneumonia, and had a discharge diagnosis of pneumonia. All eligible patients were identified and a random sample was abstracted. We determined whether the use of guideline-concordant antibiotics was associated with 30-day mortality in an analysis that adjusted for potential confounders using propensity scores. Information was obtained on 420 patients with pneumonia. The mean (± SD) age was 63 ± 16 years, 355 were men, and 82 patients were initially admitted to the intensive care unit. At 30 days after presentation, 41 patients (9.8%) had died: 21 of 97 (21.7%) in the non-guideline-concordant group and 20 of 323 (6.2%) in the guideline-concordant group. Antibiotics were concordant with national guidelines in 323 patients. In the regression analysis, after adjustment for the propensity score, failure to comply with antimicrobial therapy guidelines was associated with increased 30-day mortality (odds ratio = 5.7; 95% confidence interval: 2.0 to 16.0). Receipt of antimicrobial regimens concordant with national published guidelines may reduce 30-day mortality among patients hospitalized with pneumonia. Am J Med. 2004;117:726 -731.

UR - http://www.scopus.com/inward/record.url?scp=8344262268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8344262268&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2004.06.028

DO - 10.1016/j.amjmed.2004.06.028

M3 - Article

C2 - 15541321

AN - SCOPUS:8344262268

VL - 117

SP - 726

EP - 731

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 10

ER -